Login to Your Account

Other News To Note

Wednesday, May 16, 2012
• Furiex Pharmaceuticals Inc., of Morrisville, N.C., and Menarini Group, of Florence, Italy, said they entered a license deal giving Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East, while Furiex will retain full development and commercialization rights in the U.S., Japan and Canada.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription